Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

PubWeight™: 2.21‹?› | Rank: Top 2%

🔗 View Article (PMID 10884226)

Published in Science on July 07, 2000

Authors

D S Geller1, A Farhi, N Pinkerton, M Fradley, M Moritz, A Spitzer, G Meinke, F T Tsai, P B Sigler, R P Lifton

Author Affiliations

1: Howard Hughes Medical Institute, Department of Genetics, Yale University School of Medicine, Boyer Center for Molecular Medicine, Room 154, 295 Congress Avenue, New Haven, CT 06510, USA.

Articles citing this

Atherosclerosis. Nature (2000) 15.95

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95

Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest (2002) 2.47

Genetics of human cardiovascular disease. Cell (2012) 1.90

The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal (2007) 1.89

Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. Cell Metab (2013) 1.72

Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin. Proc Natl Acad Sci U S A (2001) 1.64

Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45

Mineralocorticoid receptors: distribution and activation. Heart Fail Rev (2005) 1.28

Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet (2012) 1.28

Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet (2009) 1.21

In hypertension, the kidney is not always the heart of the matter. J Clin Invest (2005) 1.17

Regulation of transport in the connecting tubule and cortical collecting duct. Compr Physiol (2012) 1.16

Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor. PLoS Biol (2010) 1.15

Evolution of a new function by degenerative mutation in cephalochordate steroid receptors. PLoS Genet (2008) 1.14

Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. Exp Cell Res (2012) 1.08

Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J (2013) 1.07

A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J Biol Chem (2010) 1.07

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet (2000) 1.07

Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res (2003) 1.06

The inextricable role of the kidney in hypertension. J Clin Invest (2014) 1.05

Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genet (2009) 1.00

Genetics of hypertension: from experimental animals to humans. Biochim Biophys Acta (2009) 1.00

A critical role of helix 3-helix 5 interaction in steroid hormone receptor function. Proc Natl Acad Sci U S A (2005) 1.00

Af17 deficiency increases sodium excretion and decreases blood pressure. J Am Soc Nephrol (2011) 1.00

MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem Biophys Res Commun (2009) 0.99

Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci U S A (2002) 0.98

Heritable forms of hypertension. Pediatr Nephrol (2007) 0.98

Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97

Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production. PLoS One (2008) 0.94

Central regulation of blood pressure by the mineralocorticoid receptor. Mol Cell Endocrinol (2011) 0.92

A novel vasopressin-induced transcript promotes MAP kinase activation and ENaC downregulation. EMBO J (2002) 0.92

Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles. J Comput Aided Mol Des (2010) 0.92

Pseudohypoaldosteronism in a neonate presenting as life-threatening arrhythmia. Endocrinol Diabetes Metab Case Rep (2014) 0.92

Genetics talks to epigenetics? The interplay between sequence variants and chromatin structure. Curr Genomics (2010) 0.86

Structural analysis of the evolution of steroid specificity in the mineralocorticoid and glucocorticoid receptors. BMC Evol Biol (2007) 0.86

The multifaceted mineralocorticoid receptor. Compr Physiol (2014) 0.85

Blood pressure and human genetic variation in the general population. Curr Opin Cardiol (2010) 0.85

Renal tubular transport and the genetic basis of hypertensive disease. Clin Exp Nephrol (2005) 0.85

Matching the right drug to the right patient in essential hypertension. Heart (2001) 0.84

Low renin hypertension. Indian J Endocrinol Metab (2012) 0.84

Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine. Integr Blood Press Control (2013) 0.84

Purification and characterization of recombinant human mineralocorticoid receptor. Mol Cell Endocrinol (2008) 0.83

Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators. J Biol Chem (2011) 0.81

Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension. J Clin Endocrinol Metab (2012) 0.81

Metabolic syndrome components in murine models. Endocr Metab Immune Disord Drug Targets (2010) 0.81

Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth? J Cardiovasc Pharmacol (2016) 0.80

Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes. Heart Fail Rev (2005) 0.80

Primary hypertension and special aspects of hypertension in older children and adolescents. Adolesc Health Med Ther (2011) 0.80

Association of aldosterone and cortisol with cardiovascular risk factors in prehypertension stage. Int J Hypertens (2012) 0.79

Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA. PLoS One (2014) 0.79

The molecular basis of blood pressure variation. Pediatr Nephrol (2012) 0.78

Associations of Renin-Angiotensin-Aldosterone System Genes With Blood Pressure Changes and Hypertension Incidence. Am J Hypertens (2015) 0.78

Helix 3-helix 5 interactions in steroid hormone receptor function. J Steroid Biochem Mol Biol (2008) 0.78

Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1. J Biol Chem (2015) 0.77

Arterial hypertension with brachydactyly in a 15-year-old boy. Pediatr Nephrol (2003) 0.76

Hyperaldosteronism: recent concepts, diagnosis, and management. Postgrad Med J (2001) 0.76

Paraparesis secondary to hypokalaemia with hyporeninemic hypoaldosteronism during pregnancy: a diagnostic dilemma. Obstet Med (2013) 0.75

Animal models for the study of primary and secondary hypertension in humans. Biomed Rep (2016) 0.75

Personalized medicine and treatment approaches in hypertension: current perspectives. Integr Blood Press Control (2016) 0.75

Kidney disease in African Americans: genetic considerations. J Natl Med Assoc (2002) 0.75

The Pharmacogenomics of Anti-Hypertensive Therapy. Pharmaceuticals (Basel) (2010) 0.75

A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction. PLoS One (2016) 0.75

Genetic disorders of nuclear receptors. J Clin Invest (2017) 0.75

Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism. Clin Biochem Rev (2013) 0.75

Why some people prefer pickle juice: the research of Dr. Richard P. Lifton. Yale J Biol Med (2007) 0.75

Articles cited by this

Hypertension. Mutation points to salt recycling pathway. Science (2000) 2.64

Articles by these authors

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83

Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science (1989) 8.98

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71

Crystal structure of a yeast TBP/TATA-box complex. Nature (1993) 7.95

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am (1987) 7.63

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (1991) 7.46

Crystal structure of trp repressor/operator complex at atomic resolution. Nature (1988) 7.34

The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature (1997) 7.33

The 2.0 A crystal structure of a heterotrimeric G protein. Nature (1996) 6.77

The crystal structure of the bacterial chaperonin GroEL at 2.8 A. Nature (1994) 6.72

Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07

Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science (1999) 6.04

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 5.95

Crystal structure of a G-protein beta gamma dimer at 2.1A resolution. Nature (1996) 5.87

The organization of the histone genes in Drosophila melanogaster: functional and evolutionary implications. Cold Spring Harb Symp Quant Biol (1978) 5.60

The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S. Nature (1993) 4.83

Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet (1995) 4.45

Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature (1992) 4.12

Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc Natl Acad Sci U S A (1995) 4.10

The centrosome and cellular organization. Annu Rev Biochem (1994) 4.01

Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet (1996) 3.84

Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet (1999) 3.73

Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet (1996) 3.71

The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell (1999) 3.67

GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4. Nature (1994) 3.66

Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell (1995) 3.65

Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature (1995) 3.59

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 3.58

Three-dimensional structure of tosyl-alpha-chymotrypsin. Nature (1967) 3.57

Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet (1997) 3.51

Distinct actions of cis and trans ATP within the double ring of the chaperonin GroEL. Nature (1997) 3.48

Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45

The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature (1988) 3.41

Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (1995) 3.32

The three-dimensional structure of trp repressor. Nature (1985) 3.26

Transcriptional activation. Acid blobs and negative noodles. Nature (1988) 3.24

Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. Nature (1994) 3.13

Isolation of specific RNA's using DNA covalently linked to diazobenzyloxymethyl cellulose or paper. Methods Enzymol (1979) 3.04

Interfacial catalysis: the mechanism of phospholipase A2. Science (1990) 2.84

Atomic structure of progesterone complexed with its receptor. Nature (1998) 2.83

The 2.4 A crystal structure of the bacterial chaperonin GroEL complexed with ATP gamma S. Nat Struct Biol (1996) 2.81

Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism. J Mol Biol (1968) 2.72

Purification and characterization of trp aporepressor. Proc Natl Acad Sci U S A (1983) 2.70

A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A (1995) 2.69

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A (1998) 2.68

Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure (2001) 2.66

Depletion of Saccharomyces cerevisiae ribosomal protein L16 causes a decrease in 60S ribosomal subunits and formation of half-mer polyribosomes. Genes Dev (1988) 2.59

The 3 A crystal structure of yeast initiator tRNA: functional implications in initiator/elongator discrimination. EMBO J (1991) 2.54

Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin. Cell (1996) 2.49

Crystal structure at 2.2 A resolution of the pleckstrin homology domain from human dynamin. Cell (1994) 2.41

Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J (1996) 2.39

Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet (2000) 2.38

The crystal structure of trp aporepressor at 1.8 A shows how binding tryptophan enhances DNA affinity. Nature (1987) 2.34

Determinants of repressor/operator recognition from the structure of the trp operator binding site. Nature (1994) 2.22

A dynamic model for the allosteric mechanism of GroEL. J Mol Biol (2000) 2.20

Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 A. Nature (2001) 2.20

Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr (1976) 2.20

Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int (2001) 2.18

Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16

IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12

A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A (1995) 2.10

The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem (1997) 2.10

Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension (2001) 1.99

The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity. Cell (1999) 1.96

Structural basis of preinitiation complex assembly on human pol II promoters. EMBO J (2000) 1.90

GCP5 and GCP6: two new members of the human gamma-tubulin complex. Mol Biol Cell (2001) 1.90

Structure of the oligomerization and L-arginine binding domain of the arginine repressor of Escherichia coli. J Mol Biol (1996) 1.87

Orientation of the transcription preinitiation complex in archaea. Proc Natl Acad Sci U S A (1999) 1.84

The 2.1-A crystal structure of an archaeal preinitiation complex: TATA-box-binding protein/transcription factor (II)B core/TATA-box. Proc Natl Acad Sci U S A (1997) 1.82

Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77

Crystal structure of a eukaryotic initiator tRNA. Nature (1979) 1.75

Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. J Urol (1992) 1.75

The structural basis for the oriented assembly of a TBP/TFB/promoter complex. Proc Natl Acad Sci U S A (1999) 1.73

Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet (1998) 1.73

Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.65

How does arrestin respond to the phosphorylated state of rhodopsin? J Biol Chem (1999) 1.65

A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom. J Biol Chem (1985) 1.65

The crystal structure of a hyperthermophilic archaeal TATA-box binding protein. J Mol Biol (1996) 1.63

The connecting tubule is the main site of the furosemide-induced urinary acidification by the vacuolar H+-ATPase. Kidney Int (2006) 1.60

A thermodynamic study of the trp repressor-operator interaction. J Mol Biol (1994) 1.60

Intrarenal control of proximal tubular reabsorption of sodium and water. Nephron (1969) 1.58

Effect of peritubular oncotic pressure changes on proximal tubular fluid reabsorption. Am J Physiol (1970) 1.56

Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A (1998) 1.52

False positive mononucleosis screening test results associated with Klebsiella hepatic abscess. Am J Clin Pathol (1990) 1.51

Cloning of the NCX2 isoform of the plasma membrane Na(+)-Ca2+ exchanger. J Biol Chem (1994) 1.48

Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46

A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel. EMBO J (1997) 1.46

An analysis of the structure of tRNA. Annu Rev Biophys Bioeng (1975) 1.45

Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43

The basis for half-site specificity explored through a non-cognate steroid receptor-DNA complex. Nat Struct Biol (1995) 1.40

Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet (1997) 1.39

A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. Transplantation (1989) 1.39

In vivo studies with a toxic fraction of Pseudomonas aeruginosa. Proc Soc Exp Biol Med (1970) 1.38

Enhanced rates of cleavage and development for sheep zygotes cultured to the blastocyst stage in vitro in the absence of serum and somatic cells: amino acids, vitamins, and culturing embryos in groups stimulate development. Biol Reprod (1994) 1.38

Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Galpha protein pair in yeast. Biochemistry (1998) 1.35

GroEL/GroES: structure and function of a two-stroke folding machine. J Struct Biol (1998) 1.34

Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet (1992) 1.34